ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,786Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 307

$1.27M Total Retail Price of All Prescriptions

Rank: 5 out of 307

402 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 402 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

14% of this provider’s 402 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 14,747 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $88 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
NAMENDA 543 506 1 43
SIMVASTATIN 526 448 2 5
FUROSEMIDE 514 448 3 4
LISINOPRIL 495 406 4 6
METOPROLOL TARTRATE 480 426 5 9
LEVOTHYROXINE SODIUM 478 434 6 7
DONEPEZIL HCL 426 379 7 37
SERTRALINE HCL 383 327 8 29
POTASSIUM CHLORIDE 378 300 9 13
AMLODIPINE BESYLATE 372 310 10 3
MIRTAZAPINE 359 329 11 57
LANTUS 296 201 12 85
OMEPRAZOLE 277 246 13 1
CITALOPRAM HBR 270 229 14 28
CARVEDILOL 231 166 15 12
GABAPENTIN 225 155 16 8
LEVETIRACETAM 218 155 17 83
RISPERIDONE 200 191 18 33
PLAVIX 196 175 19 52
JANTOVEN 194 161 20 154
WARFARIN SODIUM 183 164 21 14
PANTOPRAZOLE SODIUM 181 143 22 31
METOPROLOL SUCCINATE 179 157 23 11
EXELON 170 169 24 210
NOVOLIN R 167 117 25 168
CYMBALTA 163 134 26 40
TRAMADOL HCL 151 133 27 16
HUMALOG 151 117 27 282
HYDROCHLOROTHIAZIDE 146 135 29 18
CIPROFLOXACIN HCL 146 126 29 35
TRAZODONE HCL 145 125 31 34
CLOPIDOGREL 140 113 32 27
LEVOFLOXACIN 140 118 32 133
METFORMIN HCL 138 94 34 15
ATENOLOL 138 117 34 42
ATORVASTATIN CALCIUM 128 108 36 17
PRAVASTATIN SODIUM 127 92 37 25
ENOXAPARIN SODIUM 125 102 38 303
ESCITALOPRAM OXALATE 120 104 39 90
CEFTRIAXONE 119 101 40 314
CRESTOR 119 111 40 30
ISOSORBIDE MONONITRATE ER 119 89 40 49
NEXIUM 117 86 43 21
RANITIDINE HCL 117 110 43 93
HYDROCODONE-ACETAMINOPHEN 116 88 S3 45 2
LOSARTAN POTASSIUM 115 114 46 22
TAMSULOSIN HCL 111 104 47 10
HYDRALAZINE HCL 105 100 48 73
NITROFURANTOIN MONO-MACRO 101 73 49 148
ABILIFY 100 63 50 77
CARBIDOPA-LEVODOPA 99 92 51 152
ALLOPURINOL 96 78 52 39
OLANZAPINE 93 91 53 121
OXYCODONE-ACETAMINOPHEN 92 73 S2 54 38
CLONIDINE HCL 91 62 55 44
AMIODARONE HCL 87 75 56 166
AMOX TR-POTASSIUM CLAVULANATE 83 72 57 161
DIVALPROEX SODIUM 83 56 57 91
MUPIROCIN 82 57 59 114
FINASTERIDE 81 75 60 26
FAMOTIDINE 80 57 61 128
PREVACID 79 65 62 278
PREDNISONE 76 68 63 19
LIDODERM 75 69 64 301
ADVAIR DISKUS 72 53 65 60
GENERLAC 70 60 66 245
AZITHROMYCIN 70 58 66 71
CYCLOBENZAPRINE HCL 65 35 R 68 48
LANTUS SOLOSTAR 65 57 68 178
GLIPIZIDE 62 48 70 116
NOVOLOG 59 37 71 177
ENALAPRIL MALEATE 59 58 71 89
SPIRIVA 58 54 73 69
BUMETANIDE 56 56 74 231
HUMULIN R 55 34 75 394
FENTANYL 54 46 S2 76 67
EXFORGE HCT 53 41 77 272
FLUOXETINE HCL 52 43 78 82
NITROGLYCERIN PATCH 51 46 79 222
METOCLOPRAMIDE HCL 51 40 79 176
ALENDRONATE SODIUM 50 50 81 65
QUETIAPINE FUMARATE 50 45 81 75
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 40 81 92
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 13, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.